NCT06683482Completed
A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain
Ethnographic Study on Advanced Breast Cancer Patients and Their Caregivers in Spain
Source: ClinicalTrials.gov · Last updated 6 Aug 2025
Brief summary (registry, in English)
The main goal of this ethnographic study is to learn a holistic and enriched view of the behaviors, actions, and views of a group of people with advanced breast cancer (ABC) cancer living in Spain. The primary objective of this study is to collect data on the psychosocial needs of (ABC) patients to identify spaces and strategies to improve these needs.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 41 (actual)
- First submitted
- 8 Nov 2024
- Start date
- 21 Feb 2025
- Primary completion date
- 28 Jul 2025
- Lead sponsor
- Gilead Sciences
- Diseases
- Metastatic breast cancer
- NCT number
- NCT06683482
What you commit to
- Study type: Observational
- Participants enrolled: 41
- From 21 Feb 2025 to the primary completion date, 28 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individual unable to collaborate in the collection of necessary information (alteration in mental status, noncollaboration, limited language comprehension).
- Individual unable or unwilling to provide informed consent.
- Note: Other protocol defined Inclusion/Exclusion criteria may apply
Who the study is looking for
- Informed consent to individual in the qualitative study and to allow the recording of the interview for analyses purposes (individual and/or caregiver).
- Women or men (individual and/or caregiver) over 18 years of age.
- Confirmed diagnosis of triple-negative breast cancer (TNBC), hormone receptor (HR)+/ human epidermal growth factor receptor 2 (HER2)-, HER2+ unresectable locally advanced breast cancer (ULABC) or metastatic breast cancer (mBC) (individual).
- Individuals must have initiated at least the firstline treatment.
- Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale 0-2 (individual).
- Ability to conduct interviews from home (individual and/or caregiver) or remotely (ie, with technology available for an online interview).
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Salvetti & Llombart Sl Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.